US20020016349A1 - UV-B filters - Google Patents
UV-B filters Download PDFInfo
- Publication number
- US20020016349A1 US20020016349A1 US09/885,967 US88596701A US2002016349A1 US 20020016349 A1 US20020016349 A1 US 20020016349A1 US 88596701 A US88596701 A US 88596701A US 2002016349 A1 US2002016349 A1 US 2002016349A1
- Authority
- US
- United States
- Prior art keywords
- acid
- formulation
- filter
- radical
- filter substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 claims abstract description 98
- 238000009472 formulation Methods 0.000 claims abstract description 58
- -1 C1-8-alkoxy Chemical group 0.000 claims abstract description 57
- 239000002537 cosmetic Substances 0.000 claims abstract description 34
- 238000002360 preparation method Methods 0.000 claims abstract description 30
- 239000004904 UV filter Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 23
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000008569 process Effects 0.000 claims abstract description 16
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims abstract description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 42
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 13
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 7
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 7
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims description 7
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical group C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 5
- KYWYSZMDQAEHBX-UHFFFAOYSA-N 2-[4-(6-sulfo-1h-benzimidazol-2-yl)phenyl]-3h-benzimidazole-5-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2NC(C3=CC=C(C=C3)C=3NC4=CC=C(C=C4N=3)S(=O)(=O)O)=NC2=C1 KYWYSZMDQAEHBX-UHFFFAOYSA-N 0.000 claims description 4
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 4
- 239000001117 sulphuric acid Substances 0.000 claims description 4
- 235000011149 sulphuric acid Nutrition 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims description 3
- 229960001679 octinoxate Drugs 0.000 claims description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 230000006750 UV protection Effects 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000012071 phase Substances 0.000 description 60
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 235000014113 dietary fatty acids Nutrition 0.000 description 21
- 239000000194 fatty acid Substances 0.000 description 21
- 229930195729 fatty acid Natural products 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 239000002253 acid Substances 0.000 description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000003755 preservative agent Substances 0.000 description 16
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 239000000470 constituent Substances 0.000 description 13
- 239000000499 gel Substances 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 239000001993 wax Substances 0.000 description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 230000000475 sunscreen effect Effects 0.000 description 10
- 239000000516 sunscreening agent Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 230000004224 protection Effects 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 235000013772 propylene glycol Nutrition 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 8
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229930003799 tocopherol Natural products 0.000 description 7
- 239000011732 tocopherol Substances 0.000 description 7
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000000265 homogenisation Methods 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 6
- 229960003415 propylparaben Drugs 0.000 description 6
- ATVKWBAMWLLBPS-UHFFFAOYSA-N 1h-benzimidazole-4,6-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2N=CNC2=C1 ATVKWBAMWLLBPS-UHFFFAOYSA-N 0.000 description 5
- LAZCEBMOVLQWQH-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole-4,6-disulfonic acid Chemical compound N=1C2=CC(S(=O)(=O)O)=CC(S(O)(=O)=O)=C2NC=1C1=CC=CC=C1 LAZCEBMOVLQWQH-UHFFFAOYSA-N 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 0 *C1=C(C)C(C)=C(C)C(C)=C1C Chemical compound *C1=C(C)C(C)=C(C)C(C)=C1C 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 230000002633 protecting effect Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- XUXJUXSPSJCCLG-UHFFFAOYSA-N CC.CC.CC1=C(C)C(C)=C(C2=NC3=CC=CC=C3N2)C(C)=C1C Chemical compound CC.CC.CC1=C(C)C(C)=C(C2=NC3=CC=CC=C3N2)C(C)=C1C XUXJUXSPSJCCLG-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 3
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 235000019172 retinyl palmitate Nutrition 0.000 description 3
- 239000011769 retinyl palmitate Substances 0.000 description 3
- 229940108325 retinyl palmitate Drugs 0.000 description 3
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 235000010215 titanium dioxide Nutrition 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 235000014692 zinc oxide Nutrition 0.000 description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-SZSCBOSDSA-N 2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound OC[C@H](O)C1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-SZSCBOSDSA-N 0.000 description 2
- FHCBGGAPSRVQCN-UHFFFAOYSA-N 2-[1-[1-(2-hexyldodecoxy)propan-2-yloxy]propan-2-yloxy]ethyl acetate Chemical compound CCCCCCCCCCC(CCCCCC)COCC(C)OCC(C)OCCOC(C)=O FHCBGGAPSRVQCN-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- ZGQCCCCFGADNFJ-UHFFFAOYSA-N CC.II.NC1=CC=CC=C1N Chemical compound CC.II.NC1=CC=CC=C1N ZGQCCCCFGADNFJ-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 206010041303 Solar dermatitis Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 150000001556 benzimidazoles Polymers 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940120511 oleyl erucate Drugs 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940098760 steareth-2 Drugs 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- SOTIVFLSRYUZMA-UHFFFAOYSA-N 1h-benzimidazole-2,4-disulfonic acid Chemical compound C1=CC=C2NC(S(=O)(=O)O)=NC2=C1S(O)(=O)=O SOTIVFLSRYUZMA-UHFFFAOYSA-N 0.000 description 1
- QJTLTFSARPROII-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-1h-benzimidazole-4,6-disulfonic acid Chemical compound CCOC1=CC=CC(C=2NC3=C(C=C(C=C3N=2)S(O)(=O)=O)S(O)(=O)=O)=C1 QJTLTFSARPROII-UHFFFAOYSA-N 0.000 description 1
- PQKNWPRQHSURBK-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1h-benzimidazole-4,6-disulfonic acid Chemical compound COC1=CC=CC(C=2NC3=C(C=C(C=C3N=2)S(O)(=O)=O)S(O)(=O)=O)=C1 PQKNWPRQHSURBK-UHFFFAOYSA-N 0.000 description 1
- QLXJVQUMYYGTGL-UHFFFAOYSA-N 2-(4-ethoxyphenyl)-1h-benzimidazole-4,6-disulfonic acid Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC(S(O)(=O)=O)=CC(S(O)(=O)=O)=C2N1 QLXJVQUMYYGTGL-UHFFFAOYSA-N 0.000 description 1
- QIMSFWBKSHTZGP-UHFFFAOYSA-N 2-(4-methoxyphenyl)-1h-benzimidazole-4,6-disulfonic acid Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC(S(O)(=O)=O)=CC(S(O)(=O)=O)=C2N1 QIMSFWBKSHTZGP-UHFFFAOYSA-N 0.000 description 1
- LYLOSUMZZKYEDT-UHFFFAOYSA-N 2-[4-(4,6-disulfo-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2NC(C3=CC=C(C=C3)C=3NC4=C(C=C(C=C4N=3)S(=O)(=O)O)S(O)(=O)=O)=NC2=C1 LYLOSUMZZKYEDT-UHFFFAOYSA-N 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- VXLKZBRLFFGAQT-UHFFFAOYSA-N 3h-benzimidazole-5-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N=CNC2=C1 VXLKZBRLFFGAQT-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- DEQLBNCAMJUSNM-UHFFFAOYSA-N 6-methylheptyl 2-methoxy-3-phenylprop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C(OC)=CC1=CC=CC=C1 DEQLBNCAMJUSNM-UHFFFAOYSA-N 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- IBSKUGMYHRUVPR-UHFFFAOYSA-N CC1=CC(S(=O)(=O)O)=C2NC(C3=CC=CC=C3)=NC2=C1.CC1=CC(S(=O)(=O)[O-])=C2NC(C3=CC=CC=C3)=[NH+]C2=C1.O=[SH](=O)C1=C2NC(C3=CC=CC=C3)=NC2=CC(S(=O)(=O)O)=C1 Chemical compound CC1=CC(S(=O)(=O)O)=C2NC(C3=CC=CC=C3)=NC2=C1.CC1=CC(S(=O)(=O)[O-])=C2NC(C3=CC=CC=C3)=[NH+]C2=C1.O=[SH](=O)C1=C2NC(C3=CC=CC=C3)=NC2=CC(S(=O)(=O)O)=C1 IBSKUGMYHRUVPR-UHFFFAOYSA-N 0.000 description 1
- LFWFGUFVMZBZRK-UHFFFAOYSA-M COC1=CC=C(C(=O)CC(=O)C2=CC=C(C(C)(C)C)C=C2)C=C1.[V]I Chemical compound COC1=CC=C(C(=O)CC(=O)C2=CC=C(C(C)(C)C)C=C2)C=C1.[V]I LFWFGUFVMZBZRK-UHFFFAOYSA-M 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- KJQFBVYMGADDTQ-CVSPRKDYSA-N L-buthionine-(S,R)-sulfoximine Chemical compound CCCCS(=N)(=O)CC[C@H](N)C(O)=O KJQFBVYMGADDTQ-CVSPRKDYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Polymers N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical class CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- DRVWBEJJZZTIGJ-UHFFFAOYSA-N cerium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Ce+3].[Ce+3] DRVWBEJJZZTIGJ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- BWUPRNSPZFPYEK-UHFFFAOYSA-N dichloro(diethyl)germane Chemical compound CC[Ge](Cl)(Cl)CC BWUPRNSPZFPYEK-UHFFFAOYSA-N 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical group C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003722 gum benzoin Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N nordihydroguaiaretic acid Chemical compound C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000011252 protective cream Substances 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-M succinate(1-) Chemical compound OC(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-M 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to a 2-phenyl-benzimidazolesulfonic acids, to the use thereof as a UV filter, to cosmetic preparations which comprise these compounds, and to a preparation process for the compounds.
- a number of performance UV filters have been developed which, applied to the skin in the form of creams, lotions or gels, can effectively delay the development of sunburn even when the incidence of solar rays is relatively high.
- the UV filter present in the pharmaceutical or cosmetic formulation forms a film or a layer on the surface of the skin and does not penetrate into deeper skin layers with other substances present in the formulation.
- Known UV filters or sun protection agents thus act only by absorbing certain regions of sunlight; meaning that this radiation cannot penetrate into deeper layers of the skin.
- the most hazardous part of solar radiation is formed by the ultraviolet rays having a wavelength of less than 400 nm.
- the lower limit of the ultraviolet rays which reach the surface of the earth is limited by the absorption in the ozone layer to about 280 nm or above.
- the sun protection filters which are currently customary in cosmetics absorb in a wavelength range from 280 to 400 nm.
- This range includes UV-B rays having a wavelength between 280 and 320 nm, which play a decisive role in the formation of a solar erythema, and UV-A rays, having a wavelength between 320 and 400 nm, which tan the skin but also age it, and favor the triggering of an erythematous reaction or can exacerbate this reaction in certain people or even trigger phototoxic or photoallergic and irritative reactions.
- the object of skin care cosmetics is to obtain the impression of a youthful skin.
- existing skin damage such as irregular pigmentation or the development of wrinkles can be smoothed out by covering powders or creams.
- Another approach is to protect the skin against environmental influences which lead to permanent damage and thus aging of the skin.
- UV absorbers for cosmetic and dermatological preparations are divided into UV-A and UV-B absorbers.
- UV-A absorbers usually also absorb in the UV-B region and are thus alternatively referred to as broad-band absorbers or broad-band filters.
- UV-B filters are of particular importance, since formulations based on broad-band filters alone offer inadequate protection or prevent entirely the desired tanning of the skin. For this reason, there is a continuous need for substances having an absorption maximum in the UV-B region which can be incorporated easily into cosmetic formulations.
- the oil-soluble UV-B filters include isooctyl methoxycinnamate, isoamyl methoxycinnamate and methylbenzylidenecamphor.
- water-soluble UV filters are, in particular, the salts of 2-phenylbenzimidazole-5-sulfonic acid, the use of which as UV ray filter has already been described in German Reichspatent No. 676 103.
- the present invention accordingly firstly provides 2-phenylbenzimidazolesulfonic acids of the formula I
- R1, R2, R3, R4 and R5 are each a radical from the group H, C 1-8 -alkyl, C 1-8 -alkoxy, hydroxyl, sulfate, nitro, F, Cl, Br or I radicals, and R6 is a C 1-18 -alkyl or C- 1-8 -alkoxy radical.
- 2-phenyl-benzimidazolesulfonic acids are here in principle also understood as meaning the salts of these acids.
- the salts are preferably the alkali metal salts, and in particular the sodium or potassium salts, or the ammonium salts, in particular the triethanolammonium salts of the corresponding sulfonic acids.
- 2-phenylbenzimidiazole-4,6-disulfonic acid which, as shown in formula Ia, is usually in betaine form.
- the 2-phenylbenzimidazolesulfonic acid according to the invention can be obtained by any desired preparation process suitable for this purpose. Processes which have proven particularly suitable and economical are those in which an ortho-phenylenediamine or a derivative thereof is reacted with an arylcarboxylic acid or an arylcarboxylic acid derivative.
- the present invention thus secondly provides a process for the preparation of the abovedescribed 2-phenylbenzimidazolesulfonic acids, in which an o-phenylenediamine according to formula II
- R1, R2, R3, R4 and R5 in each case independently of one another, are a radical from the group of H, C 1-8 -alkyl, C- 1-8 -alkoxy, hydroxyl, nitro, F, Cl, Br or I radicals, and X is chosen from the radicals —COOH, —COCl, —COBr, —CN or —COOR, where R is a C 1-20 -alkyl radical.
- sulfuric acid in particular 96% sulfuric acid
- solvent is used as solvent.
- the sulfuric acid on its own effects sulfonation of the benzimidazole at a suitable temperature.
- international application WO 93/15061 has already described a process in which monosulfonated products are obtained by reaction in sulfuric acid.
- an activated sulfuric acid is used, activation preferably being carried out by chlorosulfonic acid or sulfur trioxide.
- Sulfuric acid alone typically is not strong enough to act as a reagent for this process because it is believed that water forms during the reaction and dilutes the sulfuric acid. Activation of the acid improved the reactivity of the acid in the process.
- oleum is a solution of sulfur trioxide in concentrated sulfuric acid.
- the use of sulfur trioxide (oleum) for the activation of the sulfuric acid has various advantages compared with the use of chlorosulfonic acid:
- gas (HCl) is not evolved during the reaction, meaning that pressure regulation is not necessary
- X in the second compound of formula III is a radical —COOH, i.e., that formula III is an arylcarboxylic acid.
- X in formula III is a radical —COOR, where R is a C 1-20 -alkyl radical, preferably a C 1-8 -alkyl radical and particularly preferably a methyl or ethyl radical.
- the reaction is carried out at temperatures between 20° C. and 200° C., preferably between 160° C. and 190° C.
- the reaction temperature is usually maintained for 2 to 8 hours. At reaction times of less than 2 hours, monosulfonation products are still observed, which can only be separated off from the product with difficulty.
- the sulfuric acid preferably in the form of a 50-100% solution, and in particular as a concentrated approximately 96% solution, is introduced.
- the ortho-phenylenediamine, or derivative thereof, is introduced.
- Activation with oleum e.g. a 65% solution of sulfur trioxide in sulfuric acid
- the amount of sulfur trioxide is chosen such that all of the water liberated during the reaction can be collected.
- oleum e.g. a 65% solution of sulfur trioxide in sulfuric acid
- the amount of sulfur trioxide is chosen such that all of the water liberated during the reaction can be collected.
- at least 4 mol of sulfur trioxide are used per mole of o-phenylenediamine.
- the addition of the second reactant is preferably only carried out for safety reasons after cooling to a temperature below 100° C. since the temperature of the reaction mixture may increase further as the result of the addition.
- the arylcarboxylic acid is expediently used in the ratio 1:1 to the phenylenediamine to obtain products according to the invention.
- reaction mixture is slowly heated to temperatures between 150 and 250° C., preferably between 160 and 200° C. and maintained at this temperature for 2 to 8 hours, optionally with stirring.
- the reaction mixture is then cooled, preferably to temperatures below 10° C., and hydrolyzed in water.
- the dried crude product it is preferably dissolved in sodium hydroxide solution, and the resulting solution is purified, preferably with activated carbon.
- the end-product is precipitated out of the colorless solution using an acid, preferably a mineral acid; for example sulphuric acid.
- the 2-phenylbenzimidazolesulfonic acid according to the invention is suitable as a UV-B filter substance.
- the present invention further provides for the use of a 2-phenylbenzimidazolesulfonic acid as a UV filter, in particular as a UV-B filter.
- the substances according to the invention are highly suitable for use in cosmetic formulations.
- the invention thus further relates to cosmetic formulations having UV protection properties which comprise at least one compound of formula I according to the invention.
- the protective action of these formulations against UV radiation can be improved if the formulation comprises one or more additional UV filter substances in addition to the UV filter according to the invention.
- UV filters are suitable for combination with the filter substance herein. Particular preference is given to combination with those UV filters whose physiological safety has already been demonstrated.
- UVA and UVB filters There are many tried and tested substances known from the specialist literature both for UVA and also UVB filters, such as:
- benzylidenecamphor derivatives such as 3-(4′-methylbenzylidene)-dl-camphor (e.g. Eusolex® 6300), 3-benzylidenecamphor (e.g. Mexoryl® SD), polymers of N- ⁇ (2 and 4)-[(2-oxoborn-3-ylidene)-methyl]benzyl ⁇ acrylamide (e.g. Mexoryl® SW), N,N,N,-trimethyl-4-(2-oxoborn-3-ylidenemethyl)-anilinium methylsulfate- (e.g. Mexoryl® SK) or ⁇ -(2-oxoborn-3-ylidene)toluene-4-sulfonic acid (e.g. Mexoryl® SL),
- 3-(4′-methylbenzylidene)-dl-camphor e.g. Eusolex® 6300
- 3-benzylidenecamphor e.g. Mexoryl® SD
- benzoylmethanes or dibenzoylmethanes such as 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione (e.g. Eusolex® 9020) or 4-isopropyldibenzoylmethane,
- benzophenones such as 2-hydroxy-4-methoxybenzophenone (e.g. Eusolex® 4360) or 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (e.g. Uvinul® MS-40),
- methoxycinnamic esters such as octyl methoxycinnamate (e.g. Eusolex® 2292), isopentyl 4-methoxycinnamate, e.g. as a mixture of the isomers (e.g. Neo Heliopan® E 1000),
- salicylate derivatives such as 2-ethylhexyl salicylate (e.g. Eusolex® OS), 4-isopropylbenzyl salicylate (e.g. Megasol®) or 3,3,5-trimethylcyclohexyl salicylate (e.g. Eusolex® HMS),
- benzimidazole derivatives such as 2-phenylbenzimidazole-5-sulfonic acid, and its potassium, sodium, lithium, ammonium and triethanolamine salts (e.g. Eusolex® 232), 2,2′-(1,4-phenylene)bis(1H-benzimidazole-4,6-disulfonic acid, monosodium salt) (CAS No. 180 898-37-7) and 2,2′-(1,4-phenylene)bis(1H-benzimidazole-5-sulfonic acid) and its potassium, sodium and triethanolamine salts
- 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium, lithium, ammonium and triethanolamine salts
- sodium, lithium, ammonium and triethanolamine salts e.g. Eusolex® 232
- 2,2′-(1,4-phenylene)bis(1H-benzimidazole-4,6-disulfonic acid, monosodium salt) CAS No.
- the compounds given in the list are only to be regarded as examples. It is of course also possible to use other UV filters. These organic UV filters are, and the 2-phenylbenzimidazolesulfonic acids according to the invention, are typically each incorporated into cosmetic formulations in an amount of from 0.5 to 20% by weight of the formulation, preferably in an amount of 1-15% by weight and particularly preferably in an amount of from 2 to 8% by weight per individual substance. Overall, the organic filters usually comprise up to 40% by weight, preferably 5 to 25% by weight, of the formulation, which includes the filter substance of the invention and any additional organic filter substances.
- Inorganic UV filters such as those from the group of titanium dioxides, such as, for example, coated titanium dioxide (e.g. Eusolex® T-2000, Eusolex® T-AQUA), zinc oxides (e.g. Sachtotec®), iron oxides and also cerium oxides can also be combined.
- coated titanium dioxide e.g. Eusolex® T-2000, Eusolex® T-AQUA
- zinc oxides e.g. Sachtotec®
- iron oxides and also cerium oxides can also be combined.
- These inorganic UV filters are usually incorporated into cosmetic formulations in an amount of from 0.5 to 20 per cent by weight of the overall formulation, preferably 2-10%.
- UV-A filters are used in addition to UV-B filters, then it is advantageous for most applications if the proportion of UV-B filters predominates and the ratio of UV-A filters:UV-B filters is preferably in the range 1:1 to 1:3.
- Preferred filter compounds for combination with the 2-phenylbenzimidazolesulfonic acids according to the invention preferred compounds having UV-filtering properties for the cosmetic preparations are 3-(4′-methylbenzylidine)-dl-camphor, 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione, 4-isopropyldibenzoylmethane, 2-hydroxy-4-methoxybenzo-phenone, octyl methoxycinnamate, 3,3,5-trimethylcyclohexyl salicylate, 2-ethylhexyl 4-(dimethyl-amino)benzoate, 2-ethylhexyl 2-cyano-3,3-diphenyl-acrylate, coated titanium dioxide and in particular 2-phenylbenzimidazole-5-sulfonic acid and 2,2′-(1,4-phenylene)bis(1H-benzimidazole-5-sulf
- the protecting action against oxidative stress or against the effect of free radicals can be further improved if the formulation comprises one or more antioxidants.
- amino acids e.g. glycine, histidine, tyrosine, tryptophan
- imidazoles e.g. urocanic acid
- peptides such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine)
- carotinoids e.g. ⁇ -carotene, ⁇ -carotene, lycopene
- chlorogenic acid and derivatives thereof e.g.
- thiols e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glycerylesters thereof), and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), and sulfoximine compounds (e.g.
- citric acid citric acid, lactic acid, malic acid
- humic acid bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof, vitamin C and derivatives (e.g. ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (e.g.
- vitamin A palmitate coniferyl benzoate of benzoin resin, rutin and salts of the sulfuric ester of rutin and derivatives thereof, ⁇ -glycosyl rutin, ferulic acid, furfurylidineglucitol, carosine, butylhydroxy-toluene, butylhydroxyanisol, nordihydroguaretic acid, trihydroxybutyrophenone, quercetin, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (e.g. ZnO, ZnSO 4 ), selenium and derivatives thereof (e.g. selenomethionine), and stilbenes and derivatives thereof (e.g. stilbene oxide, trans-stilbene oxide).
- benzoin resin rutin and salts of the sulfuric ester of rutin and derivatives thereof, ⁇ -glycosyl rutin, ferulic acid, furfurylidineglucitol, carosine, butylhydroxy-tol
- antioxidants are likewise suitable for use in the cosmetic formulations according to the invention.
- Known and commercial mixtures are, for example, mixtures comprising, as active ingredients, lecithin, L-(+)-ascorbyl palmitate and citric acid (e.g. Oxynex® AP), natural tocopherols, L-(+)-ascorbyl palmitate, L-(+)-ascorbic acid and citric acid (e.g. Oxynex® K LIQUID), tocopherol extracts from natural sources, L-(+)-ascorbyl palmitate, L-(+)-ascorbic acid and citric acid (e.g.
- Oxynex® L LIQUID DL- ⁇ -tocopherol, L-(+)-ascorbyl palmitate, citric acid and lecithin
- Oxynex® LM DL- ⁇ -tocopherol
- BHT butylhydroxytoluene
- L-(+)-ascorbyl palmitate citric acid
- citric acid e.g. Oxynex® 2004
- BHT butylhydroxytoluene
- the formulations according to the invention can also comprise vitamins as ingredients.
- the vitamins used are vitamins and vitamin derivatives chosen from vitamin A, vitamin A propionate, vitamin A palmitate, vitamin A acetate, retinol, vitamin B, thiamine chloride hydrochloride (vitamin B 1 ), riboflavin (vitamin B 2 ) nicotinamide, vitamin C (ascorbic acid), vitamin D, ergocalciferol (vitamin D 2 ), vitamin E, DL- ⁇ -tocopherol, tocopherol E acetate, tocopherol hydrogensuccinate, vitamin K 1 , esculin (vitamin P active ingredient), thiamine (vitamin B 1 ) nicotinic acid (niacin), pyridoxine, pyridoxal, pyridoaxmine, (vitamin B6), panthothenic acid, biotin, folic acid and cobalamine (vitamin B 12 ) are present in the cosmetic formulations according to
- the cosmetic or pharmaceutical formulations according to the invention can take a number of terms, such as: solutions, suspensions, emulsions, PIT emulsions, pastes, ointments, gels, creams, lotions, powders, soaps, surfactant-containing cleansing preparations, oils, aerosols and sprays. Examples of other application forms are sticks, shampoos and shower preparations. Any customary carriers, auxiliaries and optionally further active ingredients may be added to the formulation.
- Preferred auxiliaries originate from the group of preservatives, antioxidants, stabilizers, solubility promoters, vitamins, colorants, odour improvers.
- Ointments, pastes, creams and gels may comprise the customary carriers, e.g. animal and vegetable fats, waxes, paraffins, starch, tragacanth, cellulose derivatives, polyethylene glycols, silicones, bentonites, silica, talc and zinc oxide or mixtures of these substances.
- customary carriers e.g. animal and vegetable fats, waxes, paraffins, starch, tragacanth, cellulose derivatives, polyethylene glycols, silicones, bentonites, silica, talc and zinc oxide or mixtures of these substances.
- Powders and sprays may comprise the customary carriers, e.g. lactose, talc, silica, aluminium hydroxide, calcium silicate and polyamide powder or mixtures of these substances.
- Sprays can additionally comprise customary propellants, e.g. chlorofluorocarbons, propane/butane or dimethyl ether.
- Solutions and emulsions can comprise the customary carriers, such as solvents, solubility promoters and emulsifiers, e.g. water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol, oils, in particular cotton seed oil, peanut oil, wheatgerm oil, olive oil, castor oil and sesame oil, glycerol fatty acid ester, polyethylene glycols and fatty acid esters of sorbitan or mixtures of these substances.
- solvents such as solvents, solubility promoters and emulsifiers, e.g. water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol, oils, in particular cotton seed oil,
- Suspensions can comprise the customary carriers such as liquid diluents, e.g. water, ethanol or propylene glycol, suspending agents, e.g. ethoxylated isostearyl alcohols, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, microcrystalline cellulose, aluminium metahydroxide, bentonite, agar agar and tragacanth or mixtures of these substances.
- liquid diluents e.g. water, ethanol or propylene glycol
- suspending agents e.g. ethoxylated isostearyl alcohols, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, microcrystalline cellulose, aluminium metahydroxide, bentonite, agar agar and tragacanth or mixtures of these substances.
- Soaps can comprise the customary carriers, such as alkali metal salts of fatty acids, salts of fatty acid mono esters, fatty acid protein hydrolysates, isethionates, lanolin, fatty alcohol, vegetable oils, plant extracts, glycerol, sugars or mixtures of these substances.
- customary carriers such as alkali metal salts of fatty acids, salts of fatty acid mono esters, fatty acid protein hydrolysates, isethionates, lanolin, fatty alcohol, vegetable oils, plant extracts, glycerol, sugars or mixtures of these substances.
- Surfactant-containing cleansing products can comprise the customary carrier substances, such as salts of fatty alcohol sulfates, fatty alcohol ether sulfates, sulfosuccinic monoesters, fatty acid protein hydrolysates, isethionates, imidazolinium derivatives, methyl taurates, sarcosinates, fatty acid amide ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable and synthetic oils, lanolin derivatives, ethoxylated glycerol fatty acid esters or mixtures of these substances.
- customary carrier substances such as salts of fatty alcohol sulfates, fatty alcohol ether sulfates, sulfosuccinic monoesters, fatty acid protein hydrolysates, isethionates, imidazolinium derivatives, methyl taurates, sarcosinates, fatty acid
- Face and body oils can comprise the customary carrier substances such as synthetic oils, such as fatty acid esters, fatty alcohols, silicone oils, natural oils, such as vegetable oils and oily plant extracts, paraffin oils, lanolin oils or mixtures of these substances.
- synthetic oils such as fatty acid esters, fatty alcohols, silicone oils, natural oils, such as vegetable oils and oily plant extracts, paraffin oils, lanolin oils or mixtures of these substances.
- Cosmetic application forms also typical forms such as lipsticks, lip care sticks, mascara, eyeliner, eye shadow, blusher, powder makeup, emulsion make-up and wax make-up, and such protection products such as sunscreen, pre-sun and after-sun preparations.
- the cosmetic formulation according to the invention is particularly suitable for protecting human skin against the harmful influences of the UV constituents in sunlight. It can also offer protection to the skin against aging processes of the skin and against oxidative stress, i.e. against damage caused by free radicals, as are produced, for example, by solar irradiation, heat or other influences. In this connection, it is in various forms customarily used for this application.
- the formulation may be in the form of a lotion or emulsion, such as in the form of a cream or milk (O/W, W/O, O/W/O, W/O/W), in the form of oily-alcoholic, oily-aqueous or aqueous-alcoholic gels or solutions, in the form of solid sticks or may be formulated as an aerosol.
- a lotion or emulsion such as in the form of a cream or milk (O/W, W/O, O/W/O, W/O/W)
- oily-alcoholic, oily-aqueous or aqueous-alcoholic gels or solutions in the form of solid sticks or may be formulated as an aerosol.
- the formulation may comprise cosmetic auxiliaries which are customarily used in this type of preparation, such as thickeners, softeners, moisturizers, surface-active agents, emulsifiers, preservatives, antifoams, perfumes, waxes, lanolin, propellants, dyes and/or pigments which color the composition itself or the skin, and other ingredients customarily used in cosmetics.
- cosmetic auxiliaries such as thickeners, softeners, moisturizers, surface-active agents, emulsifiers, preservatives, antifoams, perfumes, waxes, lanolin, propellants, dyes and/or pigments which color the composition itself or the skin, and other ingredients customarily used in cosmetics.
- an oil, wax or other fatty substance, a lower monoalcohol or a lower polyol or mixtures thereof as a dispersant or solubilizer.
- Preferred monoalcohols or polyols include ethanol, isopropanol, propylene glycol, glycerol and sorbitol.
- a preferred embodiment of the invention is an emulsion in the form of a protective cream or milk and which, apart from the 2-phenylbenzimidazolesulfonic acid(s) according to the invention and preferably further UV filters, comprise, for example, fatty alcohols, fatty acids, fatty acid esters, in particular triglycerides of fatty acids, lanolin, natural and synthetic oils or waxes and emulsifiers in the presence of water.
- Further preferred embodiments include oily lotions based on natural or synthetic oils and waxes, lanolin, fatty acid esters, in particular triglycerides of fatty acids, or oily-alcoholic lotions based on a lower alcohol, such as ethanol, or a glycerol, such as propylene glycol, and/or a polyol, such as glycerol, and oils, waxes and fatty acid esters, such as triglycerides of fatty acids.
- a lower alcohol such as ethanol
- a glycerol such as propylene glycol
- a polyol such as glycerol
- the cosmetic preparation according to the invention can also be in the form of an alcoholic gel which comprises one or more lower alcohols or polyols, such as ethanol, propylene glycol or glycerol, and a thickener, such as siliceous earth.
- the oily-alcoholic gels also comprise natural or synthetic oil or wax.
- the solid sticks consist of natural or synthetic waxes and oils, fatty alcohols, fatty acids, fatty acid esters, lanolin and other fatty substances.
- the customary propellants such as alkanes, fluoroalkanes and chlorofluoroalkanes are usually used.
- the cosmetic formulation can also be used to protect the hair against photochemical damage in order to prevent changes of color shades, decoloration or damage of a mechanical nature.
- a suitable formulation is in the form of a shampoo, lotion, gel or emulsion for rinsing out, the formulation in question being applied before or after shampooing, before or after coloring or bleaching or before or after permanent waving. It is also possible to choose a formulation in the form of a lotion or gel for styling or treating the hair, in the form of a lotion or gel for brushing or blow-waving, in the form of a hair lacquer, permanent waving composition, colorant or bleach for the hair.
- the cosmetic formulation may comprise various adjuvants used in this type of composition, such as surface-active agents, thickeners, polymers, softeners, preservatives, foam stabilizers, electrolytes, organic solvents, silicone derivatives, oils, waxes, antigrease agents, dyes and/or pigments which color the composition itself or the hair, or other ingredients customarily used for hair care.
- adjuvants used in this type of composition such as surface-active agents, thickeners, polymers, softeners, preservatives, foam stabilizers, electrolytes, organic solvents, silicone derivatives, oils, waxes, antigrease agents, dyes and/or pigments which color the composition itself or the hair, or other ingredients customarily used for hair care.
- the cosmetic preparations according to the invention can be prepared using techniques which are well known to the person skilled in the art.
- a cosmetic preparation comprising the compound of the invention is applied to the skin or the hair.
- Sensitized hair is understood here as meaning hair which has been subjected to a chemical treatment, such as a permanent waving treatment, a coloring process or bleaching process.
- the compound of the invention also has a stabilizing effect on the formulation.
- the formulations are thus also stable for longer and do not change their appearance.
- the effectiveness of the ingredients e.g. vitamins, is retained. This is particularly advantageous in the case of compositions for protecting the skin against the effect of UV rays since these cosmetics are exposed to particularly high stresses by UV radiation.
- the invention further provides for the stabilization of particular UV filters.
- a known high-performance class of light protection filter substances is formed by the dibenzoylmethane derivatives.
- a disadvantage is that these substances are very readily decomposed by UV light and thus their protecting properties are lost.
- An example of a light protection filter from this compound class which is available commercially is 4-(tert-butyl)-4′-methoxydibenzoylmethane, which has the structure given in formula IV. IV.
- the compound of the invention has a very good stabilizing action for the dibenzoylmethanes, in particular 4-(tert-butyl)-4-methoxybenzoylmethane.
- the compound of the invention has a very good stabilizing action for the dibenzoylmethanes, in particular 4-(tert-butyl)-4-methoxybenzoylmethane.
- Antaron® V-220 is sold by GAF, Frechen, DE,
- Carbomer Ultrez-10 is supplied by Goodrich, Neuss, DE,
- Dehymuls® E is a mixture of dicocoylpentaerythritol citrate, sorbitol sesquioleate, beeswax and aluminium stearate and is sold by Cogni, Roermond, NL,
- HMS are UV filters sold by Merck KGaA, Darmstadt, DE,
- Luvitol® EHO is sold by BASF AG, Ludwigshafen, DE,
- Pemulen® TR-1 and Pemulen® TR-2 are acrylate/alkyl acrylate polymers sold by Goodrich, Neuss, DE,
- Oxynex® K is a mixture of PEG-8, tocopherol, ascorbyl palmitate, ascorbic acid and citric acid and is sold by Merck KGaA, Darmstadt, DE.
- Phase B is slowly added with stirring to Phase A. Following homogenization, the mixture is cooled with stirring.
- the preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
- Phase Ingredient % by wt. A Eusolex ®2292 (Art. No. 105382) 7.50 Eusolex ®HMS (Art. No. 111412) 7.00 Steareth-2 0.40 Steareth-10 0.80 Pemulen ®TR-2 0.18 Propylene glycol isoceteth-3 acetate 5.00 Performa ®V 825 0.80 Dimethicone 1.00 Oxynex ®K (Art. No. 108324) 0.10 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Eusolex ®232 (Art. No. 105372) 1.00 Triethanolamine 0.90 1,2-Propanediol 2.00 Water, demineralized ad 100.00
- Phase B is slowly added with stirring to Phase A. After homogenization, the mixture is cooled with stirring.
- the preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
- Phase Ingredient % by wt. A 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Eusolex ®232 (Art. No. 105372) 4.00 Sodium hydroxide solution 6.00 Glycerol 3.00 1,2-Propanediol 2.00 Preservative q.s. Water, demineralized ad 100.00 B Carbomer Ultrez-10 0.70 Water, demineralized 60.00 C Sodium hydroxide solution (10%) 1.50 Water, demineralized 4.00
- Phase A the water is first added to the sodium hydroxide solution.
- the Eusolex® 232 is added and completely dissolved with stirring. After a clear solution has been obtained, the other constituents of Phase A are added. Phase A is added in portions to the mixture of Phases B and C, the mixture being homogenized after each addition.
- Phase Ingredient % by wt. A Eusolex ® 6300 (Art. No. 5385) 0.75 Luvitol ® EHO 10.00 Dimethicone 2.00 Shea butter 5.00 Antaron ® V-220 2.00 Oxynex ® K 1.00 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Eusolex ®232 (Art. No. 105372) 0.75 Tris(hydroxymethyl)aminomethane 0.33 Preservative q.s. Water, demineralized 20.00 C Tris(hydroxymethyl)aminomethane 1.20 Water, demineralized 10.00 D Pemulen ® TR-1 0.60 Water, demineralized ad 100.00
- the Pemulen® TR-1 is dissolved in the water of Phase D.
- the tris(hydroxymethyl)aminomethane is dissolved in the water of Phase C and the solution is added to Phase D.
- the tris(hydroxymethyl)aminomethane is dissolved in the water of Phase B and, with stirring, the Eusolex® 232 is added.
- the other constituents of Phase B are added and Phase B is added to the mixture of Phases C and D and homogenized.
- the constituents of Phase A are combined and heated.
- Phase D is added to the mixture of the other phases with homogenization.
- the preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
- Phase Ingredient % by wt. A Eusolex ® 6300 (Art. No. 5385) 0.75 Luvitol ® EHO 10.00 Dimethicone 2.00 Shea butter 5.00 Antaron ® V-220 2.00 Oxynex ® K liquid (Art. No. 8324) 1.00 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid 2,2′-(1,4-Phenylene)bis(1H- 0.75 benzimidazole-4,6-disulfonic acid) Tris(hydroxymethyl)aminomethane 0.33 Preservative q.s. Water, demineralized 20.00 C Tris(hydroxymethyl)aminomethane 1.20 Water, demineralized 10.00 D Pernulen ® TR-1 0.60 Water, demineralized ad 100.00
- the Pemulen® TR-1 is dissolved in the water of Phase D.
- the tris(hydroxymethyl)aminomethane is dissolved in the water of Phase C and the solution is added to Phase D.
- the tris(hydroxymethyl)aminomethane is dissolved in the water of Phase B and the 2-phenylbenzimidazole-4,6-disulfonic acid and the 2,2′-(1,4-phenylene)bis(1H-benzimidazole-4,6-disulfonic acid) is added with stirring.
- the other constituents of Phase B are added, and Phase B is added to the mixture of Phases C and D and homogenized.
- the constituents of Phase A are combined and heated. Phase A is added to the mixture of the other phases with homogenization.
- the preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
- Phase Ingredient % by wt. A Eusolex ® 2292 (Art. No. 105382) 3.00 Eusolex ® 4360 (Art. No. 105376) 2.00 Dehymuls ® E 6.00 Hydrogenated castor oil 1.00 Beeswax 2.00 Oleyl erucate 6.00 Decyl oleate 6.00 Dimethicone 1.00 Dicapryl ether 5.00 B Glycerol (87%) 5.00 2-Phenylbenzimidazole-4,6-disulfonic 3.00 acid Magnesium sulfate heptahydrate 1.00 Preservative q.s. Water, demineralized ad 100.00
- Phase A is heated to 75° C. and Phase B is heated separately to 80° C. Phase B is added to Phase A with homogenization. The mixture is cooled with stirring.
- Phase Ingredient % by wt. A Eusolex ® 2292 (Art. No. 105382) 3.00 Eusolex ® 4360 (Art. No. 105376) 2.00 Dehymuls ® E 6.00 Hydrogenated castor oil 1.00 Beeswax 2.00 Oleyl erucate 6.00 Decyl oleate 6.00 Dimethicone 1.00 Dicapryl ether 5.00 B 2-Phenylbenzimidazole-4,6-disulfonic 2.00 acid 2,2′-(1,4-Phenylene)bis(1H- 2.00 benzimidazole-5-sulfonic acid) Glycerol (87%) 5.00 Magnesium sulfate heptahydrate 1.00 Preservative q.s. Water, demineralized ad 100.00
- Phase A is heated to 75° C. and, separately, Phase B is heated to 80° C. Phase B is added to Phase A with homogenization. The mixture is cooled with stirring.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Filtering Materials (AREA)
- Water Treatment By Sorption (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
in which
n is 0, 1 or 2 and
m is 2 or 3,
R1, R2, R3, R4 and R5, are each a radical such as H, C1-8-alkyl, C1-8-alkoxy, hydroxyl, sulfate, nitro, F, Cl, Br or I radicals, and
R6 is a C1-8-alkyl or C1-8-alkoxy radical.
This compound can be effectively used as a UV filter, and as part of a cosmetic formulation which comprise these compounds. A process for preparation of the compound is disclosed as well.
Description
- The present invention relates to a 2-phenyl-benzimidazolesulfonic acids, to the use thereof as a UV filter, to cosmetic preparations which comprise these compounds, and to a preparation process for the compounds.
- A suntan of the skin to whatever degree is regarded in today's society as attractive and as an expression of vigor and health. As well as this desired effect of the sun on the skin, however, a number of undesired secondary effects arise, such as sunburn or premature skin aging and the development of wrinkles. A number of performance UV filters have been developed which, applied to the skin in the form of creams, lotions or gels, can effectively delay the development of sunburn even when the incidence of solar rays is relatively high.
- The UV filter present in the pharmaceutical or cosmetic formulation forms a film or a layer on the surface of the skin and does not penetrate into deeper skin layers with other substances present in the formulation. Known UV filters or sun protection agents thus act only by absorbing certain regions of sunlight; meaning that this radiation cannot penetrate into deeper layers of the skin.
- As is known, the most hazardous part of solar radiation is formed by the ultraviolet rays having a wavelength of less than 400 nm. The lower limit of the ultraviolet rays which reach the surface of the earth is limited by the absorption in the ozone layer to about 280 nm or above. The sun protection filters which are currently customary in cosmetics absorb in a wavelength range from 280 to 400 nm. This range includes UV-B rays having a wavelength between 280 and 320 nm, which play a decisive role in the formation of a solar erythema, and UV-A rays, having a wavelength between 320 and 400 nm, which tan the skin but also age it, and favor the triggering of an erythematous reaction or can exacerbate this reaction in certain people or even trigger phototoxic or photoallergic and irritative reactions.
- The object of skin care cosmetics is to obtain the impression of a youthful skin. In principle, there are various ways of achieving this object. For example, existing skin damage, such as irregular pigmentation or the development of wrinkles can be smoothed out by covering powders or creams. Another approach is to protect the skin against environmental influences which lead to permanent damage and thus aging of the skin.
- The idea is therefore to intervene in a preventative manner and thus to delay the aging process. One example of this is the UV filters already mentioned which, as a result of absorption of certain wavelength regions, prevent or at least reduce skin damage. Depending on the position of their absorption maxima, UV absorbers for cosmetic and dermatological preparations are divided into UV-A and UV-B absorbers. UV-A absorbers usually also absorb in the UV-B region and are thus alternatively referred to as broad-band absorbers or broad-band filters. However, particularly in avoiding skin damage as a result of the formation of solar erythemas, the UV-B filters are of particular importance, since formulations based on broad-band filters alone offer inadequate protection or prevent entirely the desired tanning of the skin. For this reason, there is a continuous need for substances having an absorption maximum in the UV-B region which can be incorporated easily into cosmetic formulations.
- Of decisive importance for the formulation is the solubility of the filter substances in the oil and water phases since it is necessary, particularly for establishing a high protection factor, to incorporate filters into all phases of a formulation. The oil-soluble UV-B filters include isooctyl methoxycinnamate, isoamyl methoxycinnamate and methylbenzylidenecamphor. Examples of water-soluble UV filters are, in particular, the salts of 2-phenylbenzimidazole-5-sulfonic acid, the use of which as UV ray filter has already been described in German Reichspatent No. 676 103.
- However, a disadvantage of these water-soluble UV-B filters is that formulation is only possible in an alkaline medium since the sulfonic acid precipitates out at a pH below 7.
- There is thus also a need for water-soluble UV-B filters which are highly suitable for the formulation of cosmetic formulations.
- It has now surprisingly been found that certain 2-phenylbenzimidazolesulfonic acids and salts thereof can be readily incorporated into cosmetic formulations, while avoiding the above-mentioned problems.
-
- in which n is 0, 1 or 2 and m is 2 or 3. R1, R2, R3, R4 and R5 are each a radical from the group H, C1-8-alkyl, C1-8-alkoxy, hydroxyl, sulfate, nitro, F, Cl, Br or I radicals, and R6 is a C1-18-alkyl or C-1-8-alkoxy radical.
- For the purposes of the present invention, 2-phenyl-benzimidazolesulfonic acids are here in principle also understood as meaning the salts of these acids. The salts are preferably the alkali metal salts, and in particular the sodium or potassium salts, or the ammonium salts, in particular the triethanolammonium salts of the corresponding sulfonic acids.
- In a preferred 2-phenylbenzimidazolesulfonic acid according to formula I, m=2 and n=0 or n=1, preferably at least 4 radicals from the group R1, R2, R3, R4 and R5 are H, and particularly preferably even all radicals R1-R5 are H. According to the invention, particular preference is accordingly given to 2-phenylbenzimidiazole-4,6-disulfonic acid which, as shown in formula Ia, is usually in betaine form.
- The 2-phenylbenzimidazolesulfonic acid according to the invention can be obtained by any desired preparation process suitable for this purpose. Processes which have proven particularly suitable and economical are those in which an ortho-phenylenediamine or a derivative thereof is reacted with an arylcarboxylic acid or an arylcarboxylic acid derivative.
-
-
- where R1, R2, R3, R4 and R5, in each case independently of one another, are a radical from the group of H, C1-8-alkyl, C-1-8-alkoxy, hydroxyl, nitro, F, Cl, Br or I radicals, and X is chosen from the radicals —COOH, —COCl, —COBr, —CN or —COOR, where R is a C1-20-alkyl radical.
- In a preferred embodiment of the process, sulfuric acid, in particular 96% sulfuric acid, is used as solvent. Here, even the sulfuric acid on its own effects sulfonation of the benzimidazole at a suitable temperature. Thus, international application WO 93/15061 has already described a process in which monosulfonated products are obtained by reaction in sulfuric acid.
- However, in the process for the preparation of polysulfonated benzimidazoles, it is preferred if an activated sulfuric acid is used, activation preferably being carried out by chlorosulfonic acid or sulfur trioxide. Sulfuric acid alone typically is not strong enough to act as a reagent for this process because it is believed that water forms during the reaction and dilutes the sulfuric acid. Activation of the acid improved the reactivity of the acid in the process.
- The use of chlorosulfonic acid for the preparation of bisbenzimidazoloylsulfonic acids has already been described in European patent application EP-A-669 323.
- However, there are no indications that it is also possible to use chlorosulfonic acid to prepare the compounds according to the invention in the specification.
- If the activation is carried out using sulfur trioxide, use is preferably made of the “fuming” sulfuric acid called oleum, which is a solution of sulfur trioxide in concentrated sulfuric acid. The use of sulfur trioxide (oleum) for the activation of the sulfuric acid has various advantages compared with the use of chlorosulfonic acid:
- gas (HCl) is not evolved during the reaction, meaning that pressure regulation is not necessary,
- accordingly, the collection and disposal of the aggressive gas (HCl) is not required,
- while extremely corrosion-resistant apparatuses are required for the chloride-containing sulfuric acid which is formed if chlorosulfonic acid is used, the process with oleum can be carried out in less complex equipment,
- after hydrolysis of the oleum, sulfuric acid is present which can be recycled, with relative ease while the recycling of the chloride-containing sulfuric acid resulting from the use of chlorosulfonic acid is only possible with difficulty.
- As a result of these advantages, it is preferred according to the present invention to activate the sulfuric acid using sulfur trioxide (oleum).
- If the process according to the invention is carried out with activated sulfuric acid, then it is preferred that X in the second compound of formula III is a radical —COOH, i.e., that formula III is an arylcarboxylic acid. In another likewise preferred embodiment of the process, X in formula III is a radical —COOR, where R is a C1-20-alkyl radical, preferably a C1-8-alkyl radical and particularly preferably a methyl or ethyl radical.
- Here, it is particularly preferred that the reaction is carried out at temperatures between 20° C. and 200° C., preferably between 160° C. and 190° C. The reaction temperature is usually maintained for 2 to 8 hours. At reaction times of less than 2 hours, monosulfonation products are still observed, which can only be separated off from the product with difficulty.
- Implementation of the process according to the invention is in itself straightforward for one skilled in the art. A preferred embodiment for carrying out the reaction is given below. This may serve as an example, but does not limit the possible embodiments for carrying out the reaction:
- The sulfuric acid, preferably in the form of a 50-100% solution, and in particular as a concentrated approximately 96% solution, is introduced. The ortho-phenylenediamine, or derivative thereof, is introduced. Activation with oleum (e.g. a 65% solution of sulfur trioxide in sulfuric acid) is then carried out at a temperature preferably below 150° C. The amount of sulfur trioxide is chosen such that all of the water liberated during the reaction can be collected. For example, for the preparation of a benzimidazole-disulfonic acid, at least 4 mol of sulfur trioxide are used per mole of o-phenylenediamine.
- The addition of the second reactant (arylcarboxylic acid or arylcarboxylic acid derivative) is preferably only carried out for safety reasons after cooling to a temperature below 100° C. since the temperature of the reaction mixture may increase further as the result of the addition. The arylcarboxylic acid is expediently used in the ratio 1:1 to the phenylenediamine to obtain products according to the invention.
- The reaction mixture is slowly heated to temperatures between 150 and 250° C., preferably between 160 and 200° C. and maintained at this temperature for 2 to 8 hours, optionally with stirring. The reaction mixture is then cooled, preferably to temperatures below 10° C., and hydrolyzed in water.
- After the mixture has been stirred briefly, preferably 20 minutes to 2 hours, the solid constituents are separated off, preferably washed with warm water and dried.
- To purify the dried crude product, it is preferably dissolved in sodium hydroxide solution, and the resulting solution is purified, preferably with activated carbon. The end-product is precipitated out of the colorless solution using an acid, preferably a mineral acid; for example sulphuric acid.
- Because of its absorption maxima in the UV-B region, the 2-phenylbenzimidazolesulfonic acid according to the invention is suitable as a UV-B filter substance.
- Accordingly, the present invention further provides for the use of a 2-phenylbenzimidazolesulfonic acid as a UV filter, in particular as a UV-B filter.
- Because of this use option, the substances according to the invention are highly suitable for use in cosmetic formulations. The invention thus further relates to cosmetic formulations having UV protection properties which comprise at least one compound of formula I according to the invention.
- The protective action of these formulations against UV radiation can be improved if the formulation comprises one or more additional UV filter substances in addition to the UV filter according to the invention.
- In principle, it appears that all UV filters are suitable for combination with the filter substance herein. Particular preference is given to combination with those UV filters whose physiological safety has already been demonstrated. There are many tried and tested substances known from the specialist literature both for UVA and also UVB filters, such as:
- benzylidenecamphor derivatives, such as 3-(4′-methylbenzylidene)-dl-camphor (e.g. Eusolex® 6300), 3-benzylidenecamphor (e.g. Mexoryl® SD), polymers of N-{(2 and 4)-[(2-oxoborn-3-ylidene)-methyl]benzyl}acrylamide (e.g. Mexoryl® SW), N,N,N,-trimethyl-4-(2-oxoborn-3-ylidenemethyl)-anilinium methylsulfate- (e.g. Mexoryl® SK) or α-(2-oxoborn-3-ylidene)toluene-4-sulfonic acid (e.g. Mexoryl® SL),
- benzoylmethanes or dibenzoylmethanes, such as 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione (e.g. Eusolex® 9020) or 4-isopropyldibenzoylmethane,
- benzophenones, such as 2-hydroxy-4-methoxybenzophenone (e.g. Eusolex® 4360) or 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (e.g. Uvinul® MS-40),
- methoxycinnamic esters, such as octyl methoxycinnamate (e.g. Eusolex® 2292), isopentyl 4-methoxycinnamate, e.g. as a mixture of the isomers (e.g. Neo Heliopan® E 1000),
- salicylate derivatives, such as 2-ethylhexyl salicylate (e.g. Eusolex® OS), 4-isopropylbenzyl salicylate (e.g. Megasol®) or 3,3,5-trimethylcyclohexyl salicylate (e.g. Eusolex® HMS),
- 4-aminobenzoic acid and derivatives, such as 4-aminobenzoic acid, 2-ethylhexyl 4-(dimethyl-amino)benzoate (e.g. Eusolex® 6007), ethoxylated ethyl 4-aminobenzoate (e.g. Uvinul® P25),
- benzimidazole derivatives, such as 2-phenylbenzimidazole-5-sulfonic acid, and its potassium, sodium, lithium, ammonium and triethanolamine salts (e.g. Eusolex® 232), 2,2′-(1,4-phenylene)bis(1H-benzimidazole-4,6-disulfonic acid, monosodium salt) (CAS No. 180 898-37-7) and 2,2′-(1,4-phenylene)bis(1H-benzimidazole-5-sulfonic acid) and its potassium, sodium and triethanolamine salts
- and further substances, such as 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (e.g. Eusolex® OCR), 3,3-(1,4-phenylenedimethylene)bis(7,7-dimethyl-2-oxobicyclo-[2.2.1]hept-1-ylmethanesulfonic acid, and its salts (e.g. Mexoryl® SX), 2,4,6-trianilino-(p-carbo-2′-ethylhexyl-1′-oxy)-1,3,5-triazine (e.g. Uvinul® T 150), 2-(2H-benzo-triazole-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-(trimethylsilyloxy)disiloxanyl)-propyl)phenol (e.g. Silatriazole®), 4,4′-[(6-[4-((1,1,-dimethylethyl)aminocarbonyl)phenylamino]-1,3,5-triazine-2,4-diyl)diimino]bis(benzoic acid 2-ethylhexyl ester) (e.g. Uvasorb® HEB), α-trimethylsilyl)-ω-[trimethylsilyl)oxy]poly[oxy-(dimethyl [and approximately 6% methyl[2-[p-[2,2-bis(ethoxycarbonyl]vinyl]phenoxy]-1-methylene-ethyl] and about 1.5% methyl[3-[p-2,2-bis(ethoxy-carbonyl)vinyl)phenoxy)propenyl) and 0.1 to 0.4% (methylhydrogen)silylene]] (n≈60) (CAS No. 207 574-74-1), 2,2′-methylenebis(6-(2H-benzotriazole-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (CAS No. 103 597-45-1) and 2,4-bis{ [4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (CAS No. 103 597-45-[lacuna], 187 393-00-6).
- The compounds given in the list are only to be regarded as examples. It is of course also possible to use other UV filters. These organic UV filters are, and the 2-phenylbenzimidazolesulfonic acids according to the invention, are typically each incorporated into cosmetic formulations in an amount of from 0.5 to 20% by weight of the formulation, preferably in an amount of 1-15% by weight and particularly preferably in an amount of from 2 to 8% by weight per individual substance. Overall, the organic filters usually comprise up to 40% by weight, preferably 5 to 25% by weight, of the formulation, which includes the filter substance of the invention and any additional organic filter substances.
- Inorganic UV filters such as those from the group of titanium dioxides, such as, for example, coated titanium dioxide (e.g. Eusolex® T-2000, Eusolex® T-AQUA), zinc oxides (e.g. Sachtotec®), iron oxides and also cerium oxides can also be combined. These inorganic UV filters are usually incorporated into cosmetic formulations in an amount of from 0.5 to 20 per cent by weight of the overall formulation, preferably 2-10%.
- If various inorganic or organic UV filters are used, then these can be used in virtually any ratios relative to one another. The ratios of the individual substances to one another are usually in the range 1:10-10:1, preferably in the range 1:5-5:1 and particularly preferably in the range 1:2-2:1. If UV-A filters are used in addition to UV-B filters, then it is advantageous for most applications if the proportion of UV-B filters predominates and the ratio of UV-A filters:UV-B filters is preferably in the range 1:1 to 1:3.
- Preferred filter compounds for combination with the 2-phenylbenzimidazolesulfonic acids according to the invention, preferred compounds having UV-filtering properties for the cosmetic preparations are 3-(4′-methylbenzylidine)-dl-camphor, 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione, 4-isopropyldibenzoylmethane, 2-hydroxy-4-methoxybenzo-phenone, octyl methoxycinnamate, 3,3,5-trimethylcyclohexyl salicylate, 2-ethylhexyl 4-(dimethyl-amino)benzoate, 2-ethylhexyl 2-cyano-3,3-diphenyl-acrylate, coated titanium dioxide and in particular 2-phenylbenzimidazole-5-sulfonic acid and 2,2′-(1,4-phenylene)bis(1H-benzimidazole-5-sulfonic acid) and its potassium, sodium, lithium, ammoniium and triethanolamine salts.
- The protecting action against oxidative stress or against the effect of free radicals can be further improved if the formulation comprises one or more antioxidants.
- There are many tried and tested substances known from the specialist literature which can be used as an antioxidant in the formulation such as amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (e.g. urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotinoids, carotenes (e.g. α-carotene, β-carotene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, lipoic acid and derivatives thereof (e.g. dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glycerylesters thereof), and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), and sulfoximine compounds (e.g. buthionine-sulfoximine, homocysteine-sulfoximine, buthionine-sulfone, penta-, hexa- and heptathionine-sulfoximine) in very low tolerated doses (e.g. pmol to μmol/kg), and also (metal) chelating agents, (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof, vitamin C and derivatives (e.g. ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (e.g. vitamin A palmitate), and coniferyl benzoate of benzoin resin, rutin and salts of the sulfuric ester of rutin and derivatives thereof, α-glycosyl rutin, ferulic acid, furfurylidineglucitol, carosine, butylhydroxy-toluene, butylhydroxyanisol, nordihydroguaretic acid, trihydroxybutyrophenone, quercetin, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (e.g. ZnO, ZnSO4), selenium and derivatives thereof (e.g. selenomethionine), and stilbenes and derivatives thereof (e.g. stilbene oxide, trans-stilbene oxide).
- Mixtures of antioxidants are likewise suitable for use in the cosmetic formulations according to the invention. Known and commercial mixtures are, for example, mixtures comprising, as active ingredients, lecithin, L-(+)-ascorbyl palmitate and citric acid (e.g. Oxynex® AP), natural tocopherols, L-(+)-ascorbyl palmitate, L-(+)-ascorbic acid and citric acid (e.g. Oxynex® K LIQUID), tocopherol extracts from natural sources, L-(+)-ascorbyl palmitate, L-(+)-ascorbic acid and citric acid (e.g. Oxynex® L LIQUID), DL-α-tocopherol, L-(+)-ascorbyl palmitate, citric acid and lecithin (e.g. Oxynex® LM) or butylhydroxytoluene (BHT), L-(+)-ascorbyl palmitate and citric acid (e.g. Oxynex® 2004).
- The formulations according to the invention can also comprise vitamins as ingredients. Preferably, the vitamins used are vitamins and vitamin derivatives chosen from vitamin A, vitamin A propionate, vitamin A palmitate, vitamin A acetate, retinol, vitamin B, thiamine chloride hydrochloride (vitamin B1), riboflavin (vitamin B2) nicotinamide, vitamin C (ascorbic acid), vitamin D, ergocalciferol (vitamin D2), vitamin E, DL-α-tocopherol, tocopherol E acetate, tocopherol hydrogensuccinate, vitamin K1, esculin (vitamin P active ingredient), thiamine (vitamin B1) nicotinic acid (niacin), pyridoxine, pyridoxal, pyridoaxmine, (vitamin B6), panthothenic acid, biotin, folic acid and cobalamine (vitamin B12) are present in the cosmetic formulations according to the invention, particularly preferably vitamin A palmitate, vitamin C, DL-α-tocopherol, tocopherol E acetate, nicotinic acid, panthothenic acid and biotin.
- The compound according to the invention can be incorporated into cosmetic formulations in the customary manner. Suitable formulations are those for external use, such as cream, lotion, gel or as a solution which can be sprayed onto the skin. In this respect, it is preferred if the preparation comprises at least one oil phase and at least one water phase, and that the 2-phenylbenzimidazolesulfonic acid according to the invention is present in at least one aqueous phase.
- The cosmetic or pharmaceutical formulations according to the invention can take a number of terms, such as: solutions, suspensions, emulsions, PIT emulsions, pastes, ointments, gels, creams, lotions, powders, soaps, surfactant-containing cleansing preparations, oils, aerosols and sprays. Examples of other application forms are sticks, shampoos and shower preparations. Any customary carriers, auxiliaries and optionally further active ingredients may be added to the formulation.
- Preferred auxiliaries originate from the group of preservatives, antioxidants, stabilizers, solubility promoters, vitamins, colorants, odour improvers.
- Ointments, pastes, creams and gels may comprise the customary carriers, e.g. animal and vegetable fats, waxes, paraffins, starch, tragacanth, cellulose derivatives, polyethylene glycols, silicones, bentonites, silica, talc and zinc oxide or mixtures of these substances.
- Powders and sprays may comprise the customary carriers, e.g. lactose, talc, silica, aluminium hydroxide, calcium silicate and polyamide powder or mixtures of these substances. Sprays can additionally comprise customary propellants, e.g. chlorofluorocarbons, propane/butane or dimethyl ether.
- Solutions and emulsions can comprise the customary carriers, such as solvents, solubility promoters and emulsifiers, e.g. water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol, oils, in particular cotton seed oil, peanut oil, wheatgerm oil, olive oil, castor oil and sesame oil, glycerol fatty acid ester, polyethylene glycols and fatty acid esters of sorbitan or mixtures of these substances.
- Suspensions can comprise the customary carriers such as liquid diluents, e.g. water, ethanol or propylene glycol, suspending agents, e.g. ethoxylated isostearyl alcohols, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, microcrystalline cellulose, aluminium metahydroxide, bentonite, agar agar and tragacanth or mixtures of these substances.
- Soaps can comprise the customary carriers, such as alkali metal salts of fatty acids, salts of fatty acid mono esters, fatty acid protein hydrolysates, isethionates, lanolin, fatty alcohol, vegetable oils, plant extracts, glycerol, sugars or mixtures of these substances.
- Surfactant-containing cleansing products can comprise the customary carrier substances, such as salts of fatty alcohol sulfates, fatty alcohol ether sulfates, sulfosuccinic monoesters, fatty acid protein hydrolysates, isethionates, imidazolinium derivatives, methyl taurates, sarcosinates, fatty acid amide ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable and synthetic oils, lanolin derivatives, ethoxylated glycerol fatty acid esters or mixtures of these substances.
- Face and body oils can comprise the customary carrier substances such as synthetic oils, such as fatty acid esters, fatty alcohols, silicone oils, natural oils, such as vegetable oils and oily plant extracts, paraffin oils, lanolin oils or mixtures of these substances.
- Cosmetic application forms also typical forms such as lipsticks, lip care sticks, mascara, eyeliner, eye shadow, blusher, powder makeup, emulsion make-up and wax make-up, and such protection products such as sunscreen, pre-sun and after-sun preparations.
- All compounds or components which can be used in the cosmetic formulations are either known and available commercially or can be synthesized by known processes.
- The cosmetic formulation according to the invention is particularly suitable for protecting human skin against the harmful influences of the UV constituents in sunlight. It can also offer protection to the skin against aging processes of the skin and against oxidative stress, i.e. against damage caused by free radicals, as are produced, for example, by solar irradiation, heat or other influences. In this connection, it is in various forms customarily used for this application. For example, the formulation may be in the form of a lotion or emulsion, such as in the form of a cream or milk (O/W, W/O, O/W/O, W/O/W), in the form of oily-alcoholic, oily-aqueous or aqueous-alcoholic gels or solutions, in the form of solid sticks or may be formulated as an aerosol.
- The formulation may comprise cosmetic auxiliaries which are customarily used in this type of preparation, such as thickeners, softeners, moisturizers, surface-active agents, emulsifiers, preservatives, antifoams, perfumes, waxes, lanolin, propellants, dyes and/or pigments which color the composition itself or the skin, and other ingredients customarily used in cosmetics.
- It is possible to use an oil, wax or other fatty substance, a lower monoalcohol or a lower polyol or mixtures thereof as a dispersant or solubilizer. Preferred monoalcohols or polyols include ethanol, isopropanol, propylene glycol, glycerol and sorbitol.
- A preferred embodiment of the invention is an emulsion in the form of a protective cream or milk and which, apart from the 2-phenylbenzimidazolesulfonic acid(s) according to the invention and preferably further UV filters, comprise, for example, fatty alcohols, fatty acids, fatty acid esters, in particular triglycerides of fatty acids, lanolin, natural and synthetic oils or waxes and emulsifiers in the presence of water.
- Further preferred embodiments include oily lotions based on natural or synthetic oils and waxes, lanolin, fatty acid esters, in particular triglycerides of fatty acids, or oily-alcoholic lotions based on a lower alcohol, such as ethanol, or a glycerol, such as propylene glycol, and/or a polyol, such as glycerol, and oils, waxes and fatty acid esters, such as triglycerides of fatty acids.
- The cosmetic preparation according to the invention can also be in the form of an alcoholic gel which comprises one or more lower alcohols or polyols, such as ethanol, propylene glycol or glycerol, and a thickener, such as siliceous earth. The oily-alcoholic gels also comprise natural or synthetic oil or wax.
- The solid sticks consist of natural or synthetic waxes and oils, fatty alcohols, fatty acids, fatty acid esters, lanolin and other fatty substances.
- If a preparation is formulated as an aerosol, the customary propellants, such as alkanes, fluoroalkanes and chlorofluoroalkanes are usually used.
- The cosmetic formulation can also be used to protect the hair against photochemical damage in order to prevent changes of color shades, decoloration or damage of a mechanical nature. In this case, a suitable formulation is in the form of a shampoo, lotion, gel or emulsion for rinsing out, the formulation in question being applied before or after shampooing, before or after coloring or bleaching or before or after permanent waving. It is also possible to choose a formulation in the form of a lotion or gel for styling or treating the hair, in the form of a lotion or gel for brushing or blow-waving, in the form of a hair lacquer, permanent waving composition, colorant or bleach for the hair. Apart from the 2-phenyl-benzimidazolesulfonic acid(s) according to the invention and further UV filters, the cosmetic formulation may comprise various adjuvants used in this type of composition, such as surface-active agents, thickeners, polymers, softeners, preservatives, foam stabilizers, electrolytes, organic solvents, silicone derivatives, oils, waxes, antigrease agents, dyes and/or pigments which color the composition itself or the hair, or other ingredients customarily used for hair care.
- The cosmetic preparations according to the invention can be prepared using techniques which are well known to the person skilled in the art.
- To protect the skin and/or natural or sensitized hair against solar rays, a cosmetic preparation comprising the compound of the invention is applied to the skin or the hair. Sensitized hair is understood here as meaning hair which has been subjected to a chemical treatment, such as a permanent waving treatment, a coloring process or bleaching process.
- In addition, the compound of the invention also has a stabilizing effect on the formulation. When used in corresponding products, the formulations are thus also stable for longer and do not change their appearance. In particular, even in the case of longer-lasting application or relatively long storage, the effectiveness of the ingredients, e.g. vitamins, is retained. This is particularly advantageous in the case of compositions for protecting the skin against the effect of UV rays since these cosmetics are exposed to particularly high stresses by UV radiation.
- The invention further provides for the stabilization of particular UV filters. A known high-performance class of light protection filter substances is formed by the dibenzoylmethane derivatives. However, a disadvantage is that these substances are very readily decomposed by UV light and thus their protecting properties are lost. An example of a light protection filter from this compound class which is available commercially is 4-(tert-butyl)-4′-methoxydibenzoylmethane, which has the structure given in formula IV. IV.
- Surprisingly, it has now been found that the compound of the invention has a very good stabilizing action for the dibenzoylmethanes, in particular 4-(tert-butyl)-4-methoxybenzoylmethane. By incorporating mixtures of these compounds into cosmetics, it is now possible to prepare light protection compositions using dibenzoyl-methanes which show no or only a low decrease in the protective action against UV rays, even in the case of a relatively long period of solar action, for example during sunbathing for a number of hours.
- The entire disclosure of all applications, patents and publications, cited above and below, and of corresponding German Application No. 100 30 663.2, filed Jun. 23, 2000 is hereby incorporated by reference.
- The examples below illustrate the present invention in more detail.
- In the foregoing and in the following examples, all temperatures are set forth uncorrected in degrees Celsium; and, unless otherwise indicated, all parts and percentages are by weight.
- Antaron® V-220 is sold by GAF, Frechen, DE,
- Carbomer Ultrez-10 is supplied by Goodrich, Neuss, DE,
- Dehymuls® E is a mixture of dicocoylpentaerythritol citrate, sorbitol sesquioleate, beeswax and aluminium stearate and is sold by Cogni, Roermond, NL,
- Eusolex® 2292, Eusolex® 232, Eusolex® 6300 and Eusolex®
- HMS are UV filters sold by Merck KGaA, Darmstadt, DE,
- Luvitol® EHO is sold by BASF AG, Ludwigshafen, DE,
- Pemulen® TR-1 and Pemulen® TR-2 are acrylate/alkyl acrylate polymers sold by Goodrich, Neuss, DE,
- Performa V825 is a synthetic wax sold by New Phase, NJ08554, US,
- Oxynex® K is a mixture of PEG-8, tocopherol, ascorbyl palmitate, ascorbic acid and citric acid and is sold by Merck KGaA, Darmstadt, DE.
- 108 parts of o-phenylenediamine are introduced into 500 parts of H2SO4 (>96%) and then 800 parts of oleum (65%) are added dropwise, the temperature being maintained at a maximum of 120° C. After 15 min, the mixture is cooled to 70° C. and 120 parts of benzoic acid are added. The mixture is heated for 2 h at 180° C. The mixture is slowly hydrolysed with 2 500 parts of water, the temperature being maintained below 10° C. The precipitate (crystals) is filtered off with suction, the crude product is suspended in 8 parts of water and dissolved with 32% sodium hydroxide solution at pH =7. The solution is stirred with activated carbon until colorless, and thereafter precipitation is induced using 96% H2SO4 by establishing a pH=1-2. 300 parts of 2-phenylbenzimidazole-4,6-disulfonic acid are obtained. The compound has an absorption maximum in the UV-B region at λmax=308 nm.
- The following are prepared analogously:
- 2-(4′-methoxyphenyl)benzimidazole-4,6-disulfonic acid
- 2-(3′-methoxyphenyl)benzimidazole-4,6-disulfonic acid
- 2-(4′-ethoxyphenyl)benzimidazole-4,6-disulfonic acid
- 2-(3′-ethoxyphenyl)benzimidazole-4,6-disulfonic acid
- 2-(3′-5′-dimethoxyphenyl)benzimidazole-4,6-disulfonic acid
- 2-(3′-5′-diethoxyphenyl)benzimidazole-4,6-disulfonic acid
- 2-(3′-4′-diethoxyphenyl)benzimidazole-4,6-disulfonic acid.
-
Phase Ingredient % by wt. A Eusolex ®2292 (Art. No. 105382) 7.50 Eusolex ®HMS (Art. No. 111412) 7.00 Steareth-2 0.40 Steareth-10 0.80 Pemulen ® TR-2 0.18 Propylene glycol isoceteth-3 acetate 5.00 Performa ® V 825 0.80 Dimethicone 1.00 Oxynex ®K (Art. No. 108324) 0.10 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Triethanolamine 0.90 1,2-Propanediol 2.00 Preservative 0.50 Water, demineralised ad 100.00 - Preparation:
- Phase B:
- The water is mixed with the triethanolamine and the 2-phenylbenzimidazole-4,6-disulfonic acid is added with stirring. As soon as everything has dissolved, the other constituents of Phase B are added and the mixture is heated to 80° C.
- Phase A:
- The constituents of Phase A, with the exception of Pemulen® TR-2, are combined and heated to 80° C. The Pemulen® TR-2 is added with stirring.
- Preparation of the Sunscreen Composition:
- Phase B is slowly added with stirring to Phase A. Following homogenization, the mixture is cooled with stirring. The preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
-
Phase Ingredient % by wt. A Eusolex ®2292 (Art. No. 105382) 7.50 Eusolex ®HMS (Art. No. 111412) 7.00 Steareth-2 0.40 Steareth-10 0.80 Pemulen ®TR-2 0.18 Propylene glycol isoceteth-3 acetate 5.00 Performa ®V 825 0.80 Dimethicone 1.00 Oxynex ®K (Art. No. 108324) 0.10 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Eusolex ®232 (Art. No. 105372) 1.00 Triethanolamine 0.90 1,2-Propanediol 2.00 Water, demineralized ad 100.00 - Preparation:
- Phase B:
- The water is mixed with the triethanolamine and Eusolex® 232 and the 2-phenylbenzimidazole-4,6-disulfonic acid are added with stirring. As soon as everything has dissolved, the other constituents of Phase B are added and the mixture is heated to 80° C.
- Phase A:
- The constituents of Phase A, with the exception of Pemulen® TR-2, are combined and heated to 80° C. The Pemulen® TR-2 is added with stirring.
- Preparation of the Sunscreen Composition:
- Phase B is slowly added with stirring to Phase A. After homogenization, the mixture is cooled with stirring. The preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
-
Phase Ingredient % by wt. A 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Eusolex ®232 (Art. No. 105372) 4.00 Sodium hydroxide solution 6.00 Glycerol 3.00 1,2-Propanediol 2.00 Preservative q.s. Water, demineralized ad 100.00 B Carbomer Ultrez-10 0.70 Water, demineralized 60.00 C Sodium hydroxide solution (10%) 1.50 Water, demineralized 4.00 - Preparation:
- Carbomer Ultrez-10 is completely dispersed in the water of Phase B. Phase C is then slowly added and the mixture is homogenized.
- For Phase A, the water is first added to the sodium hydroxide solution. The Eusolex® 232 is added and completely dissolved with stirring. After a clear solution has been obtained, the other constituents of Phase A are added. Phase A is added in portions to the mixture of Phases B and C, the mixture being homogenized after each addition.
- The preservative used is:
- 0.20% of methyl 4-hydroxybenzoate
-
Phase Ingredient % by wt. A Eusolex ® 6300 (Art. No. 5385) 0.75 Luvitol ® EHO 10.00 Dimethicone 2.00 Shea butter 5.00 Antaron ® V-220 2.00 Oxynex ® K 1.00 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid Eusolex ®232 (Art. No. 105372) 0.75 Tris(hydroxymethyl)aminomethane 0.33 Preservative q.s. Water, demineralized 20.00 C Tris(hydroxymethyl)aminomethane 1.20 Water, demineralized 10.00 D Pemulen ® TR-1 0.60 Water, demineralized ad 100.00 - Preparation:
- The Pemulen® TR-1 is dissolved in the water of Phase D. The tris(hydroxymethyl)aminomethane is dissolved in the water of Phase C and the solution is added to Phase D. The tris(hydroxymethyl)aminomethane is dissolved in the water of Phase B and, with stirring, the Eusolex® 232 is added. After a clear solution has been obtained, the other constituents of Phase B are added and Phase B is added to the mixture of Phases C and D and homogenized. The constituents of Phase A are combined and heated. Phase D is added to the mixture of the other phases with homogenization.
- The preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
-
Phase Ingredient % by wt. A Eusolex ® 6300 (Art. No. 5385) 0.75 Luvitol ® EHO 10.00 Dimethicone 2.00 Shea butter 5.00 Antaron ® V-220 2.00 Oxynex ® K liquid (Art. No. 8324) 1.00 B 2-Phenylbenzimidazole-4,6-disulfonic 1.00 acid 2,2′-(1,4-Phenylene)bis(1H- 0.75 benzimidazole-4,6-disulfonic acid) Tris(hydroxymethyl)aminomethane 0.33 Preservative q.s. Water, demineralized 20.00 C Tris(hydroxymethyl)aminomethane 1.20 Water, demineralized 10.00 D Pernulen ® TR-1 0.60 Water, demineralized ad 100.00 - Preparation:
- The Pemulen® TR-1 is dissolved in the water of Phase D. The tris(hydroxymethyl)aminomethane is dissolved in the water of Phase C and the solution is added to Phase D. The tris(hydroxymethyl)aminomethane is dissolved in the water of Phase B and the 2-phenylbenzimidazole-4,6-disulfonic acid and the 2,2′-(1,4-phenylene)bis(1H-benzimidazole-4,6-disulfonic acid) is added with stirring. After a clear solution has been obtained, the other constituents of Phase B are added, and Phase B is added to the mixture of Phases C and D and homogenized. The constituents of Phase A are combined and heated. Phase A is added to the mixture of the other phases with homogenization.
- The preservatives used are 0.05% of propyl 4-hydroxybenzoate and 0.15% of methyl 4-hydroxybenzoate.
-
Phase Ingredient % by wt. A Eusolex ® 2292 (Art. No. 105382) 3.00 Eusolex ® 4360 (Art. No. 105376) 2.00 Dehymuls ® E 6.00 Hydrogenated castor oil 1.00 Beeswax 2.00 Oleyl erucate 6.00 Decyl oleate 6.00 Dimethicone 1.00 Dicapryl ether 5.00 B Glycerol (87%) 5.00 2-Phenylbenzimidazole-4,6-disulfonic 3.00 acid Magnesium sulfate heptahydrate 1.00 Preservative q.s. Water, demineralized ad 100.00 - Preparation:
- The constituents of Phases A and B are each combined. Phase A is heated to 75° C. and Phase B is heated separately to 80° C. Phase B is added to Phase A with homogenization. The mixture is cooled with stirring.
- The preservatives used are:
- 0.05% of propyl 4-hydroxybenzoate
- 0.15% of methyl 4-hydroxybenzoate.
-
Phase Ingredient % by wt. A Eusolex ® 2292 (Art. No. 105382) 3.00 Eusolex ® 4360 (Art. No. 105376) 2.00 Dehymuls ® E 6.00 Hydrogenated castor oil 1.00 Beeswax 2.00 Oleyl erucate 6.00 Decyl oleate 6.00 Dimethicone 1.00 Dicapryl ether 5.00 B 2-Phenylbenzimidazole-4,6-disulfonic 2.00 acid 2,2′-(1,4-Phenylene)bis(1H- 2.00 benzimidazole-5-sulfonic acid) Glycerol (87%) 5.00 Magnesium sulfate heptahydrate 1.00 Preservative q.s. Water, demineralized ad 100.00 - Preparation:
- The constituents of Phases A and B are each combined. Phase A is heated to 75° C. and, separately, Phase B is heated to 80° C. Phase B is added to Phase A with homogenization. The mixture is cooled with stirring.
- The preservatives used are:
- 0.05% of propyl 4-hydroxybenzoate
- 0.15% of methyl 4-hydroxybenzoate.
- The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.
- From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention and, without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.
Claims (25)
2. A 2-Phenylbenzimidazolesulfonic acid according to claim 1 , wherein m=2 and n=0-1, and wherein at least 4 radicals from the group R1, R2, R3, R4 and R5 are H radicals.
3. A process for the preparation of a compound according to claim 1 , wherein an o-phenylenediamine according to formula II
is reacted with a compound according to the formula III
wherein R1, R2, R3, R4 and R5, are each, independently of one another, a radical selected from H, C1-8-alkyl, C1-8-alkoxy, hydroxyl, nitro, F, Cl, Br or an I radical,
and wherein X is a radical selected from —COOH, —COCl, —COBr, —CN or —COOR,
and wherein R is a C1-20-alkyl radical.
4. A method according to claim 3 , wherein the reaction is carried out in sulfuric acid.
5. A UV filter substance comprised of a 2-phenylbenzimidazolesulfonic acid according to claim 1 .
6. A cosmetic formulation having UV protection properties comprising at least one filter substance comprised of at least one 2-phenylbenzimidazolesulfonic acid according to claim 1 .
7. A cosmetic formulation according to claim 6 , wherein the formulation comprises at least one oil phase and at least one water phase, and wherein the 2-phenylbenzimidazolesulfonic acid is present in the at least one water phase.
8. A cosmetic formulation according to claim 6 , further comprising at least one additional UV filter substance, wherein each filter substance is present in the formulation in an amount of from 0.5 to 20% by weight of the entire formulation.
9. A cosmetic formulation according to claim 6 , further comprising at least one of the following compounds 3-(4′-methylbenzylidene)-dl-camphor, 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione, 4-isopropyldibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, octyl methoxycinnamate, 3,3,5-trimethylcyclohexyl salicylate, 2-ethylhexyl 4-(dimethylamino)benzoate, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate coated titanium dioxide, 2-phenylbenzimidazole-5-sulfonic acid and 2,2′-(1,4-phenylene)bis(1H-benzimidazole-5-sulfonic acid).
10. A stabilizing substance for a UV filter comprising a 2-phenylbenzimidazolesulfonic acid according to claim 1 .
11. A method according to claim 2 , wherein the radicals R1-R5 are each an H radical.
12. A method according to claim 3 , wherein R is a C1-8 alkyl radical.
13. A method according to claim 4 , wherein the sulphuric acid is activated sulphuric acid.
14. A method according to claim 4 , wherein the reaction is carried out at a temperature of 160° C. to 190° C.
15. A method according to claim 13 , further comprising activating the sulphuric acid using chlorosulfonic acid or oleum.
16. A method according to claim 13 , further comprising activating the sulphuric acid using oleum.
17. A UV filter substance according to claim 5 , wherein the UV filter substance further comprises a UV-B filter substance.
18. A formulation according to claim 8 , wherein the filter substance is a UV-A filter substance.
19. A formulation according to claim 8 , wherein each filter substance is present in the formulation in an amount from 1 to 15% by weight of the entire formulation.
20. A formulation according to claim 8 , wherein each filter substance is presence in the formulation in an amount from 2 to 8% by weight of the entire formulation.
21. A formulation according to claim 8 , wherein the filter substances together comprise from 5 to 25% by weight of the entire formulation.
22. A formulation according to claim 6 , further comprising 2-phenylbenzimidazole-5-sulfonic acid and/or 2,2′-(1,4-phenylene)bis(1H-benzimidazole-5-sulfonic acid).
23. A substance according to claim 10 , wherein the UV filter is dibenzoylmethane or a derivative of dibenzoylmethane.
24. A formulation according to claim 6 , further comprising at least one antioxidant.
25. A formulation according to claim 6 , further comprising at least one vitamin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/989,172 US6440401B1 (en) | 2000-06-23 | 2001-11-21 | 2-phenyl-benzimidazolesulfonic acids as UV-B filters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10030663A DE10030663A1 (en) | 2000-06-23 | 2000-06-23 | UV-B filters |
DEDE10030663.2 | 2000-06-23 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/989,172 Continuation US6440401B1 (en) | 2000-06-23 | 2001-11-21 | 2-phenyl-benzimidazolesulfonic acids as UV-B filters |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020016349A1 true US20020016349A1 (en) | 2002-02-07 |
Family
ID=7646573
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/885,967 Abandoned US20020016349A1 (en) | 2000-06-23 | 2001-06-22 | UV-B filters |
US09/989,172 Expired - Fee Related US6440401B1 (en) | 2000-06-23 | 2001-11-21 | 2-phenyl-benzimidazolesulfonic acids as UV-B filters |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/989,172 Expired - Fee Related US6440401B1 (en) | 2000-06-23 | 2001-11-21 | 2-phenyl-benzimidazolesulfonic acids as UV-B filters |
Country Status (6)
Country | Link |
---|---|
US (2) | US20020016349A1 (en) |
EP (1) | EP1167358B1 (en) |
JP (1) | JP2002047275A (en) |
AT (1) | ATE276237T1 (en) |
DE (2) | DE10030663A1 (en) |
ES (1) | ES2227022T3 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040059126A1 (en) * | 2002-09-17 | 2004-03-25 | Gunter Rauchschwalbe | Process for the preparation of isolated 3,4-diaminobenzenesulphonic acid |
US20050152858A1 (en) * | 2003-07-11 | 2005-07-14 | Isp Investments Inc. | Solubilizing agents for active or functional organic compounds |
US20050202066A1 (en) * | 2003-08-28 | 2005-09-15 | Arata Andrew B. | Silver dihydrogen citrate compositions comprising a second antimicrobial agent |
US20060051430A1 (en) * | 2004-09-07 | 2006-03-09 | Arata Andrew B | Silver dihydrogen citrate compositions |
US20060067900A1 (en) * | 2004-09-29 | 2006-03-30 | Isp Investments Inc. | Method and composition for imparting high shine to a polymeric substrate |
US7435438B1 (en) | 2003-05-16 | 2008-10-14 | Pure Bioscience | Disinfectant and method of use |
US20090099257A1 (en) * | 2002-08-31 | 2009-04-16 | Arata Andrew B | Composition and process for treating acne |
US7601755B2 (en) | 2000-04-06 | 2009-10-13 | Pure Bioscience | Process for treating water |
US20100181385A1 (en) * | 2009-01-21 | 2010-07-22 | Muhlbauer Ag | Method for producing an antenna on a substrate |
US7803407B2 (en) | 1997-10-10 | 2010-09-28 | Pure Bioscience | Disinfectant and method of making |
US10278777B1 (en) | 2016-03-12 | 2019-05-07 | Philipp K. Lang | Augmented reality visualization for guiding bone cuts including robotics |
US11348257B2 (en) | 2018-01-29 | 2022-05-31 | Philipp K. Lang | Augmented reality guidance for orthopedic and other surgical procedures |
US11751944B2 (en) | 2017-01-16 | 2023-09-12 | Philipp K. Lang | Optical guidance for surgical, medical, and dental procedures |
US11786206B2 (en) | 2021-03-10 | 2023-10-17 | Onpoint Medical, Inc. | Augmented reality guidance for imaging systems |
US11801114B2 (en) | 2017-09-11 | 2023-10-31 | Philipp K. Lang | Augmented reality display for vascular and other interventions, compensation for cardiac and respiratory motion |
US11857378B1 (en) | 2019-02-14 | 2024-01-02 | Onpoint Medical, Inc. | Systems for adjusting and tracking head mounted displays during surgery including with surgical helmets |
US12053247B1 (en) | 2020-12-04 | 2024-08-06 | Onpoint Medical, Inc. | System for multi-directional tracking of head mounted displays for real-time augmented reality guidance of surgical procedures |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235249B2 (en) * | 2002-03-28 | 2007-06-26 | The Procter & Gamble Company | Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions |
DE10229526A1 (en) * | 2002-07-01 | 2004-01-15 | Beiersdorf Ag | Aqueous cosmetic and dermatological preparations containing water-soluble UV filter substances |
DE10243027A1 (en) * | 2002-09-17 | 2004-03-25 | Bayer Ag | 2-phenyl-benzimidazole-5-sulfonic acid from isolated 3,4-diaminobenzene sulfonic acid and its use in cosmetic preparations |
US20040161435A1 (en) * | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
DE102004027099A1 (en) * | 2004-05-10 | 2005-12-08 | Beiersdorf Ag | Clear and aqueous cosmetic and dermatological preparations containing oil-soluble UV filter substances |
KR100665342B1 (en) * | 2004-11-04 | 2007-01-09 | 동성제약주식회사 | Oxidized hair dye containing sunscreen |
JP4600191B2 (en) * | 2005-07-15 | 2010-12-15 | Jsr株式会社 | Novel aromatic compounds, sulfonated polyarylenes and their uses |
KR100710427B1 (en) * | 2006-03-23 | 2007-04-24 | 한국과학기술원 | Catalyst Compound for Cyclic Olefin Addition and Method for Manufacturing Cyclic Olefin Polymer |
DE102007005336A1 (en) * | 2007-02-01 | 2008-08-07 | Beiersdorf Ag | UV filter combination with piperazine derivatives |
US20110104082A1 (en) * | 2009-11-04 | 2011-05-05 | Conopco, Inc., D/B/A Unilever | Enhanced photo protection |
US8173108B2 (en) * | 2009-11-04 | 2012-05-08 | Conopco, Inc. | Sunscreen composition |
US8206691B2 (en) * | 2009-11-04 | 2012-06-26 | Conopco, Inc. | Sunscreen composition with fatty acid alkanolamides |
CN102652165B (en) * | 2009-11-24 | 2014-04-02 | 株式会社资生堂 | Clay mineral that includes ultraviolet absorber and cosmetics containing the same |
ITVR20120003A1 (en) * | 2012-01-05 | 2013-07-06 | Univ Ferrara | NEW DUALIST MOLECULES PROVIDED WITH UV FILTERING CAPACITY WITH WIDE SPECTRUM AND POWERFUL DAMPING ACTIVITY OF THE REACTIVITY OF FREE RADICALS (RADICAL SCAVENGING) |
US10449135B2 (en) | 2014-04-09 | 2019-10-22 | Basf Se | Solublizing agents for UV filters in cosmetic formulations |
US11793742B2 (en) | 2014-04-11 | 2023-10-24 | Basf Se | Mixtures of cosmetic UV absorbers |
EP3229766B1 (en) | 2014-12-09 | 2020-02-12 | Basf Se | Solubilizing agents for uv filters in cosmetic formulations |
TWI685338B (en) * | 2017-12-14 | 2020-02-21 | 柯瑞 伊里阿斯 J | Prevention and treatment of human metabolic syndrome including type 2 diabetes, steatohepatitis and related conditions using non-absorbable, orally administered compounds |
FR3124389A1 (en) * | 2021-06-28 | 2022-12-30 | L'oreal | Transparent cosmetic composition with ascorbic acid and water-soluble UV filter |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE676103C (en) * | 1933-03-31 | 1939-05-25 | I G Farbenindustrie Akt Ges | Radiation protection agents |
DE4203072C1 (en) * | 1992-02-04 | 1992-11-12 | Merck Patent Gmbh, 6100 Darmstadt, De | |
ES2157268T5 (en) | 1994-02-24 | 2004-12-01 | SYMRISE GMBH & CO KG | COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING PHENYLENE-1,4-BISBENCIMIDAZOLSULFONIC ACIDS. |
DE19713776A1 (en) * | 1997-04-03 | 1998-10-08 | Beiersdorf Ag | Light protection preparations with a content of basic amino acids and water-soluble UV filter substances |
FR2789582B1 (en) | 1999-02-12 | 2001-05-04 | Oreal | PHOTOPROTECTIVE COMPOSITIONS CONTAINING A BIS-RESORCINYL TRIAZINE DERIVATIVE AND A COMPOUND HAVING BENZOAZOLYL OR BENZODIAZOLYL GROUPINGS |
DE19923712A1 (en) * | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Active substance combination of sulfonated UV filter substances and flavone derivatives and / or flavanone derivatives, in particular flavonoids, and cosmetic preparations containing such active substance combinations |
DE19923773A1 (en) * | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Cosmetic or dermatological photoprotective preparations containing boron nitride and sulfonated UV filter substances, and the use of boron nitride for stabilizing emulsions which have a content of electrolytes, in particular a content of sulfonated UV filter substances |
-
2000
- 2000-06-23 DE DE10030663A patent/DE10030663A1/en not_active Withdrawn
-
2001
- 2001-06-20 JP JP2001185703A patent/JP2002047275A/en active Pending
- 2001-06-21 EP EP01115094A patent/EP1167358B1/en not_active Expired - Lifetime
- 2001-06-21 ES ES01115094T patent/ES2227022T3/en not_active Expired - Lifetime
- 2001-06-21 DE DE50103597T patent/DE50103597D1/en not_active Expired - Lifetime
- 2001-06-21 AT AT01115094T patent/ATE276237T1/en not_active IP Right Cessation
- 2001-06-22 US US09/885,967 patent/US20020016349A1/en not_active Abandoned
- 2001-11-21 US US09/989,172 patent/US6440401B1/en not_active Expired - Fee Related
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7803407B2 (en) | 1997-10-10 | 2010-09-28 | Pure Bioscience | Disinfectant and method of making |
US7601755B2 (en) | 2000-04-06 | 2009-10-13 | Pure Bioscience | Process for treating water |
US20090099257A1 (en) * | 2002-08-31 | 2009-04-16 | Arata Andrew B | Composition and process for treating acne |
US6787666B2 (en) | 2002-09-17 | 2004-09-07 | Bayer Chemicals Ag | Process for the preparation of isolated 3,4-diaminobenzenesulphonic acid |
US20040059126A1 (en) * | 2002-09-17 | 2004-03-25 | Gunter Rauchschwalbe | Process for the preparation of isolated 3,4-diaminobenzenesulphonic acid |
US20080319062A1 (en) * | 2003-05-16 | 2008-12-25 | Arata Andrew B | Disinfectant and method of use |
US7763297B2 (en) | 2003-05-16 | 2010-07-27 | Pure Bioscience | Disinfectant and method of use |
US7435438B1 (en) | 2003-05-16 | 2008-10-14 | Pure Bioscience | Disinfectant and method of use |
US20050152858A1 (en) * | 2003-07-11 | 2005-07-14 | Isp Investments Inc. | Solubilizing agents for active or functional organic compounds |
US7732486B2 (en) | 2003-08-28 | 2010-06-08 | Pure Bioscience | Anhydrous silver dihydrogen citrate compositions |
US20070185350A1 (en) * | 2003-08-28 | 2007-08-09 | Arata Andrew B | Anhydrous silver dihydrogen citrate compositions |
US20060100273A1 (en) * | 2003-08-28 | 2006-05-11 | Pure Bioscience | Anhydrous silver dihydrogen citrate compositions |
US20050202066A1 (en) * | 2003-08-28 | 2005-09-15 | Arata Andrew B. | Silver dihydrogen citrate compositions comprising a second antimicrobial agent |
US20060051430A1 (en) * | 2004-09-07 | 2006-03-09 | Arata Andrew B | Silver dihydrogen citrate compositions |
US20060067900A1 (en) * | 2004-09-29 | 2006-03-30 | Isp Investments Inc. | Method and composition for imparting high shine to a polymeric substrate |
US20100181385A1 (en) * | 2009-01-21 | 2010-07-22 | Muhlbauer Ag | Method for producing an antenna on a substrate |
US8348170B2 (en) | 2009-01-21 | 2013-01-08 | Mühlbauer Ag | Method for producing an antenna on a substrate |
US10405927B1 (en) | 2016-03-12 | 2019-09-10 | Philipp K. Lang | Augmented reality visualization for guiding physical surgical tools and instruments including robotics |
US11172990B2 (en) | 2016-03-12 | 2021-11-16 | Philipp K. Lang | Systems for augmented reality guidance for aligning physical tools and instruments for arthroplasty component placement, including robotics |
US10368947B2 (en) | 2016-03-12 | 2019-08-06 | Philipp K. Lang | Augmented reality guidance systems for superimposing virtual implant components onto the physical joint of a patient |
US10278777B1 (en) | 2016-03-12 | 2019-05-07 | Philipp K. Lang | Augmented reality visualization for guiding bone cuts including robotics |
US10603113B2 (en) | 2016-03-12 | 2020-03-31 | Philipp K. Lang | Augmented reality display systems for fitting, sizing, trialing and balancing of virtual implant components on the physical joint of the patient |
US10743939B1 (en) | 2016-03-12 | 2020-08-18 | Philipp K. Lang | Systems for augmented reality visualization for bone cuts and bone resections including robotics |
US10799296B2 (en) | 2016-03-12 | 2020-10-13 | Philipp K. Lang | Augmented reality system configured for coordinate correction or re-registration responsive to spinal movement for spinal procedures, including intraoperative imaging, CT scan or robotics |
US10849693B2 (en) | 2016-03-12 | 2020-12-01 | Philipp K. Lang | Systems for augmented reality guidance for bone resections including robotics |
US11013560B2 (en) | 2016-03-12 | 2021-05-25 | Philipp K. Lang | Systems for augmented reality guidance for pinning, drilling, reaming, milling, bone cuts or bone resections including robotics |
US11850003B2 (en) | 2016-03-12 | 2023-12-26 | Philipp K Lang | Augmented reality system for monitoring size and laterality of physical implants during surgery and for billing and invoicing |
US11311341B2 (en) | 2016-03-12 | 2022-04-26 | Philipp K. Lang | Augmented reality guided fitting, sizing, trialing and balancing of virtual implants on the physical joint of a patient for manual and robot assisted joint replacement |
US10292768B2 (en) | 2016-03-12 | 2019-05-21 | Philipp K. Lang | Augmented reality guidance for articular procedures |
US11452568B2 (en) | 2016-03-12 | 2022-09-27 | Philipp K. Lang | Augmented reality display for fitting, sizing, trialing and balancing of virtual implants on the physical joint of a patient for manual and robot assisted joint replacement |
US11602395B2 (en) | 2016-03-12 | 2023-03-14 | Philipp K. Lang | Augmented reality display systems for fitting, sizing, trialing and balancing of virtual implant components on the physical joint of the patient |
US11751944B2 (en) | 2017-01-16 | 2023-09-12 | Philipp K. Lang | Optical guidance for surgical, medical, and dental procedures |
US12290414B2 (en) | 2017-09-11 | 2025-05-06 | Philipp K. Lang | Augmented reality guidance for vascular procedures |
US11801114B2 (en) | 2017-09-11 | 2023-10-31 | Philipp K. Lang | Augmented reality display for vascular and other interventions, compensation for cardiac and respiratory motion |
US11348257B2 (en) | 2018-01-29 | 2022-05-31 | Philipp K. Lang | Augmented reality guidance for orthopedic and other surgical procedures |
US12086998B2 (en) | 2018-01-29 | 2024-09-10 | Philipp K. Lang | Augmented reality guidance for surgical procedures |
US11727581B2 (en) | 2018-01-29 | 2023-08-15 | Philipp K. Lang | Augmented reality guidance for dental procedures |
US11857378B1 (en) | 2019-02-14 | 2024-01-02 | Onpoint Medical, Inc. | Systems for adjusting and tracking head mounted displays during surgery including with surgical helmets |
US12053247B1 (en) | 2020-12-04 | 2024-08-06 | Onpoint Medical, Inc. | System for multi-directional tracking of head mounted displays for real-time augmented reality guidance of surgical procedures |
US11786206B2 (en) | 2021-03-10 | 2023-10-17 | Onpoint Medical, Inc. | Augmented reality guidance for imaging systems |
Also Published As
Publication number | Publication date |
---|---|
EP1167358B1 (en) | 2004-09-15 |
EP1167358A1 (en) | 2002-01-02 |
DE10030663A1 (en) | 2002-01-10 |
ATE276237T1 (en) | 2004-10-15 |
US20020055532A1 (en) | 2002-05-09 |
JP2002047275A (en) | 2002-02-12 |
US6440401B1 (en) | 2002-08-27 |
ES2227022T3 (en) | 2005-04-01 |
DE50103597D1 (en) | 2004-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6440401B1 (en) | 2-phenyl-benzimidazolesulfonic acids as UV-B filters | |
US6593476B2 (en) | Process for the preparation of UV filter substances | |
US20030207886A1 (en) | Preparation containing quinoxaline derivatives | |
US7217821B2 (en) | Photoprotective cosmetic compositions comprising para-aminobenzalmalonate-substituted s-triazine compounds | |
US20060222607A1 (en) | Tricyclic quinoxaline and quinoline derivatives as UV filters | |
EP2800741B1 (en) | Dualistic molecules having uv radiation filtrating ability at wide spectrum and potent damping activity of the reactivity of free radicals (radicals scavenging) | |
US7534421B2 (en) | s-Triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | |
JP2010539230A (en) | UV absorbing compounds | |
JP4364140B2 (en) | S-triazine derivatives having at least two silanic para-aminobenzalmalonate groups; compositions for photoprotective cosmetics containing these derivatives; use of the s-triazine derivatives | |
JP3418988B2 (en) | Sulfonic acids and their use as U / V absorbers | |
US8221730B2 (en) | Silanic para-aminobenzalmalonate-substituted s-triazine compounds and photoprotective compositions comprised thereof | |
EP1466908A1 (en) | S-tiazin-derivatives having at least one grafted para-aminobenzalmalonic acid salt and sun screening preparations comprising those derivatives | |
EP1454896A1 (en) | Amine, amide, sulfonamide and carbamate derivatives of benzylidenemalonoc acid salts photoprotective cosmetic compositions containing them | |
US6641802B2 (en) | Amino acid compounds and photoprotecting compositions comprised thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MERCK PATENT GESELLSCHAFT MIT, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HEYANG, ULRICH;SCHWARZ, MICHAEL;PFLUECKER, FRANK;REEL/FRAME:011931/0312 Effective date: 20010420 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |